Retrospective and Prospective Analyses of the Treatment of Overanticoagulated Patients

Study Objective. To compare withholding warfarin therapy with low‐dose (2.5 mg) oral vitamin K therapy in excessively anticoagulated patients without bleeding complications.

• Publication year

  1998

• Venue

  Pharmacotherapy

• Publication date

  1998-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/j.1875-9114.1998.tb03146.xPMID 9855325
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Management of venous thromboembolism.

  1997cited by this paper
• Prosthetic heart valves.

  1997cited by this paper
• Correction of Excessive Anticoagulation with Low-Dose Oral Vitamin K1

  1997cited by this paper
• REVERSING THE ANTICOAGULANT EFFECT OF WARFARIN WITH PHYTONADIONE : WHAT ISTHE RIGHT DOSE?

  1996cited by this paper
• Prosthetic heart valves.

  1996cited by this paper
• Not too conservative treatment of over anticoagulated patients.

  1996cited by this paper
• Warfarin Withdrawal

  1996cited by this paper
• Antithrombotic therapy. An abbreviated reference for clinicians.

  1995cited by this paper
• Oral Vitamin K1: An Option To Reduce Warfarin'S Activity

  1995cited by this paper
• Conservative treatment of overanticoagulated patients.

  1995cited by this paper
• Optimal intensity and monitoring warfarin.

  1995cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  1995cited by this paper
• Antithrombotic therapy. An abbreviated reference for clinicians.

  1995cited by this paper
• Interactions of Warfarin with Drugs and Food

  1994cited by this paper
• Reversal of excessive effect of regular anticoagulation: low oral dose of phytonadione (vitamin K1) compared with warfarin discontinuation.

  1993cited by this paper
• Effective Reversal of Warfarin-lnduced Excessive Anticoagulation with Low Dose Mtamin K1

  1992cited by this paper
• Hemorrhagic complications of anticoagulant treatment.

  1992cited by this paper
• Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients

  1991cited by this paper
• Long-term anticoagulation. Indications and management.

  1989cited by this paper
• Clinical Pharmacokinetic Considerations in the Control of Oral Anticoagulant Therapy

  1989cited by this paper
• The incidence, magnitude, and time course of the amiodarone-warfarin interaction.

  1988cited by this paper
• Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.

  1984cited by this paper
• Vitamin K and oral anticoagulant drugs as competitive antagonists in man.

  1972cited by this paper

• Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.

  2015cites this paper
• Reversal of Oral Anticoagulation

  2013cites this paper
• Reversal of overanticoagulation in very elderly hospitalized patients with an INR above 5.0: 24-hour INR response after vitamin K administration.

  2011cites this paper
• Hemorrhagic Complications of Anticoagulants in Hospitalized Patients

  2011cites this paper
• Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient

  2010cites this paper
• Vitamin K's Delicate Balancing Act

  2007cites this paper
• Treatment of coumarin‐associated coagulopathy: a systematic review and proposed treatment algorithms

  2006cites this paper
• Appraisal of current vitamin K dosing algorithms for the reversal of over‐anticoagulation with warfarin: the need for a more tailored dosing regimen

  2006cites this paper
• Treatment of excessive anticoagulation with phytonadione (vitamin K): a meta-analysis.

  2006cites this paper
• Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review

  2004cites this paper
• Use of Oral Vitamin K1 by Patients Taking Warfarin Sodium: Experience in an Ambulatory Care Clinic

  2003cites this paper
• Interaction of rofecoxib and celecoxib with warfarin.

  2003cites this paper
• Vitamin K for the Treatment of Asymptomatic Coagulopathy Associated with Oral Anticoagulant Therapy

  2003cites this paper
• A Retrospective Evaluation of the Management of Excessive Anticoagulation in an Established Clinical Pharmacy Anticoagulation Service Compared to Traditional Care

  2003cites this paper
• Practical tips for warfarin dosing and monitoring.

  2003cites this paper
• Management of oral anticoagulants in the treatment of venous thromboembolism.

  2001cites this paper
• Evaluation and Survey of Intravenous Vitamin K1 for Treatment of Coagulopathy in Critically Ill Patients

  2001cites this paper
• Evaluation of Very Low‐Dose Subcutaneous Vitamin K During Postoperative Warfarin Therapy

  2001cites this paper
• Randomized, Placebo‐Controlled Trial of Oral Phytonadione for Excessive Anticoagulation

  2000cites this paper
• Vitamin K to Reverse Excessive Anticoagulation: A Review of the Literature

  1999cites this paper